Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter study of antiviral treatment duration for congenital cytomegalovirus-associated sensorineural hearing loss
ChiCTR2100044233Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ganciclovir and valganciclovir in congenital cytomegalovirus infection (cCMV) (4 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Blood routine, Liver and kidney function and 6 more. Started Dec 2020; status: recruiting.
02
Drugs
ganciclovirvalganciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on ChiCTR2100044233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044233.